What is Arcus Biosciences's total carrying value of debt?

Arcus Biosciences (RCUS) reported total carrying value of debt of $100M in Q1 2026.

How has Arcus Biosciences's total carrying value of debt changed year-over-year?

Arcus Biosciences's total carrying value of debt increased by 100.0% year-over-year, from $50M to $100M.

Arcus Biosciences RCUS Total Carrying Value of Debt

Total Carrying Value of Debt at other companies

BillionToOne, Inc. BLLN

——

Jazz PharmaceuticalsJAZZ

——

Arcutis Biotherapeutics, Inc.ARQT

——

Other financials

Income statement

See full

Revenue$17.0M-39.3%

Operating income-$134.0M-9.8%

Net income-$128.0M-14.3%

EPS (diluted)-$1.02+10.5%

Balance sheet

See full

Cash & equivalents$201.0M+4.7%

Total debt$113.0M+88.3%

Total equity$524.0M-1.3%

Total assets$997.0M-13.8%

Cash flow

See full

Operating cash flow-$138.0M-4.5%

CapEx--100%

Free cash flow-$138.0M-3.8%

Valuation

See full

Market cap$3.54B+226%

Enterprise value$3.46B+275%

P/S15×+7.3×

Profitability

See full

Operating margin-168.6%-52.7pp

Net margin-156.4%-47.5pp

FCF margin-207.2%—

Returns & leverage

See full

Return on equity-70%+8.4pp

Debt / equity0.2×+0.1×

Current ratio4×-1.3×

Where this comes from

Reported directly by Arcus Biosciences in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentCarryingAmount.

The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcus Biosciences's total carrying value of debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Arcus Biosciences's total carrying value of debt?: Arcus Biosciences (RCUS) reported total carrying value of debt of $100M in Q1 2026.
How has Arcus Biosciences's total carrying value of debt changed year-over-year?: Arcus Biosciences's total carrying value of debt increased by 100.0% year-over-year, from $50M to $100M.